Effects of the stem extracts of Schisandra glaucescens Diels on collagen-induced arthritis in Balb/c mice. (24th December 2016)

• Record Type: Journal Article
• Authors: Xiang, Yan; Zhang, Tiantian; Yin, Chunpin; Zhou, Jiewen; Huang, Rong; Gao, Shasha; Zheng, Lamei; Wang, Xiaogang; Manyande, Anne; Tian, Xuebi; Chen, Jiachun; Fang, Jinbo
• Is Part Of: Journal of ethnopharmacology. Volume 194(2016)
• Page Start: 1078
• Page End: 1086
• Publication Date: 2016-12-24
• Subjects: Bu fractions extracted by n-butyl alcohol -- CIA collagen-induced arthritis -- CII type II bovine collagen -- Dex dexamethasone -- EA fractions extracted by ethylacetate -- ELISA enzyme-linked immunesorbent assay kit -- IL-1β interleukin 1 beta -- IL-6 interleukin 6 -- IL-10 interleukin 10 -- RA rheumatoid arthritis -- RANKL receptor or activator of NF-KB ligand -- SGD Schisandra glaucescens Diels; Schisandra glaucescens Diels -- Rheumatoid arthritis -- Collagen-induced arthritis (CIA) -- Immunomodulation -- Inflammatory cytokines; Ethnopharmacology -- Periodicals; Pharmacognosy -- Periodicals; Herbs -- Periodicals; Herbs -- Periodicals; Pharmacognosy -- Periodicals; Pharmacognosie -- Périodiques; Herbes -- Périodiques; 615.1
• DOI: 10.1016/j.jep.2016.11.011
• Languages: English
• ISSNs: 0378-8741

Abstract

Abstract: Ethnopharmacological relevance: Schisandra glaucescens Diels (SGD) is used in a subclass of traditional Chinese medicine known as "Tujia drugs". It has been long used for the treatment of rheumatoid arthritis (RA), cough with dyspnea, spontaneous sweating, night sweating, chronic diarrhea, and neurasthenia. As a woody liana growing in mountain jungles at the altitudes of 750–1800 m, it is mainly distributed in Sichuan and Hubei Provinces of China. Aim of the study: To evaluate the antiarthritic activity of acetate (EA) and n -butanol (Bu) fractions of SGD extract on a collagen-induced arthritis mice model. Materials and methods: Acute toxicity of EA and Bu fractions of SGD extract was evaluated by gavage on normal mice. Pharmacological investigations were conducted on arthritis male Balb/c mice. The animal model was induced by immunization with type II bovine collagen (CII) on the 1st and the 14th day of the experimental schedule. EA fraction (104, 312, 936 mg/kg), Bu fraction (156, 469, 1407 mg/kg) of SGD extract was orally administered every two days since the 15th day for 3 weeks. Progression of edema in the paws was measured using a vernier caliper every 3 days since the 10th day. At the end of the experiment, the spleen index and histological changes of the hind knee joints were investigated. Additionally, to explore the possible antirheumatic mechanisms of the EA and Bu fractions, ELISA was carried out to analyze TNF-α, IL-10, IL-6 and IL-1β in the serum. Results: The half lethal doses of both EA and Bu fractions were much higher than the dose administered in the pharmacological investigations. Oral administration of EA fraction and Bu fraction of SGD extract significantly and does-dependently inhibited type ІІ collagen induced arthritis (CIA) in mice, as indicated by the effects on paws swelling and spleen index. Histopathological examinations demonstrated that SGD effectively protected the bones and cartilages of knee joints from erosion, lesion and deformation. Besides, the serum concentrations of cytokines TNF-α, IL-1β and IL-6 were significantly lower than the ones from the vehicle control group. Respectively, while cytokine IL-10 was remarkably higher compare with the vehicle control group. Conclusions: SGD might be a safe and effective candidate for the treatment of RA, and deserves further investigation on the chemical components in both EA and Bu fractions of SGD extract. Graphical abstract: